Last reviewed · How we verify
NCT06673472
Comparison of Long-term Outcomes Between Upfront Surgery and Neoadjuvant Therapy Followed by Surgery in Patients with Node-Negative Gastric Cancer
trial in Lymph Node-negative in 1,081 participants. Completed in 15 September 2024.
4 September 2024
Quick facts
| Lead sponsor | Chang-Ming Huang, Prof. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,081 |
| Start date | 1 May 2024 |
| Primary completion | 4 September 2024 |
| Estimated completion | 15 September 2024 |
| Sites | 1 location across China |
Conditions studied
- Lymph Node-negative — all drugs for Lymph Node-negative →
- Gastric Cancer — all drugs for Gastric Cancer →
Sponsor
Chang-Ming Huang, Prof. — full company profile →
Who can join
Adults 18 to 80, any sex, with Lymph Node-negative or Gastric Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with lymph node-negative gastric cancer, the prognosis of patients who underwent neoadjuvant therapy was poor than that of those who had upfront surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06673472
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Chang-Ming Huang, Prof. trials
Trials by the same sponsor.
- NCT06716593 — Trajectory of Body Composition Identifies LAGC with Cachexia Following NACT · completed
- NCT06573307 — Hematological Dynamic Scores for Predicting Survival and Treatment Response for Advanced Gastric Cancer After Neoadjuvan · completed
- NCT06548464 — Interpretable Machine Learning Models for Prognosis in Gastric Cancer Patients · completed
- NCT06467591 — Prediction Model for Advanced Gastric Cancer in Elderly · completed
- NCT06663852 — ML Decision Model for G-NEC Adjuvant Therapy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06673472 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chang-Ming Huang, Prof.
- Last refreshed: 5 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06673472.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing